Shares of Zomedica (NYSE:ZOM) ran up nearly 15% in the two trading days following the release of the company’s fourth-quarter earnings report in late February. This was despite the veterinary diagnostics specialist reporting a surprise loss of 1 cent per share. But with ZOM stock trading lower in five out of the six trading days since, it’s likely the post-earnings rally was just a flash in the pan for this speculative play.
Read more about Zomedica stock here.
The post It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse appeared first on InvestorPlace.